Ursprung des Netzwerks ersten Grades von Kim Duffy
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kim Duffy
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer Compliance Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DOW CHEMICAL COMPANY (THE) | Chemicals: Specialty | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SonarMed, Inc.
 SonarMed, Inc. Electronic Equipment/InstrumentsElectronic Technology SonarMed, Inc. develops medical devices. It offers AirWave, a non invasive, adjunctive device that provides direct, precise, real time monitoring of endotracheal tube position and function, which may aid in detecting potentially dangerous or fatal endotracheal tube conditions. The firm’s product may help reduce endotracheal tube related risks and complications, thereby improving patient safety and quality of care as well as reducing cost of care. It operates through its offices located in Bryan and Carmel. The company was founded by Jeffrey P. Mansfield, Eduardo J. Juan and George R. Wodicka in 2005 and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Biotechnology | Director/Board Member | |
Global Pharmaceuticals Cos LLC
 Global Pharmaceuticals Cos LLC Miscellaneous Commercial ServicesCommercial Services Part of Fashion Handbags, Inc. (California), Global Pharmaceuticals Cos LLC is a company that researches and develops medical products and equipment for the urine collection and testing market. The company is based in Tampa, FL. The company was founded by Fred M. Ryan. Global Pharmaceuticals Cos was acquired by Fashion Handbags, Inc. (California) on June 24, 2003 for $104 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Utah | College/University | Undergraduate Degree | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The California State University | College/University | Graduate Degree | |
| Indiana University | College/University | Masters Business Admin | |
| Loma Linda University | College/University | Doctorate Degree Doctorate Degree | |
| North Central College | College/University | Undergraduate Degree | |
| Occidental College | College/University | Undergraduate Degree | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree | |
| MESOBLAST LIMITED | Biotechnology | Corporate Officer/Principal | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Corporate Officer/Principal | |
Riverside Partners LLC
 Riverside Partners LLC Investment ManagersFinance Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
| Healthcare Financial Management Association | Corporate Officer/Principal | ||
| Humboldt-Universität zu Berlin | College/University | Doctorate Degree | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Pharmaceuticals: Major | Director/Board Member | |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Pharmaceuticals: Major | Compliance Officer | |
Glenmark Generics, Inc.
 Glenmark Generics, Inc. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Generics, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in Mahwah, NJ. | Pharmaceuticals: Major | General Counsel | |
| Global Nutritionals, Inc. | Corporate Officer/Principal | ||
| DEUTSCHE BIOTECH INNOVATIV AG | Financial Conglomerates | Chief Tech/Sci/R&D Officer | |
| KITE PHARMA INC | Biotechnology | Director of Finance/CFO | |
| Qingdao University Medical College | College/University | Undergraduate Degree | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Kellogg School of Management | College/University | Graduate Degree | |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D’Angelo Partners Management LP(Tyree & D’Angelo Partners Management) is a private equity firm founded in 2013 by James L. Tyree, Enzo D’Angelo and Michael Tyree. The firm is headquartered in Chicago, Illinois. | Investment Managers | Founder | |
| University of Illinois College of Law | College/University | Graduate Degree | |
| University of San Francisco School of Law | College/University | Graduate Degree | |
| HEWLETT PACKARD ENTERPRISE COMPANY | Computer Processing Hardware | Corporate Officer/Principal | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
DNX Biopharmaceuticals, Inc.
 DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services DNX Biopharmaceuticals, Inc. operates as a biopharmaceuticals company. It develops long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company was founded by John Caputo, Rajiv Datar, and Howard Levine in 2014 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Director/Board Member | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ASSERTIO HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
PBS Biotech, Inc.
 PBS Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services PBS Biotech, Inc. manufactures bioreactors. The company is based in Camarillo, CA and has subsidiaries in the United States. The company was founded by Brian Lee. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Amitech Therapeutic Solutions, Inc | Chief Executive Officer | ||
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Deutschland | 4 |
| Australien | 2 |
| Dänemark | 2 |
| Italien | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Finance | 4 |
| Electronic Technology | 3 |
Operativ
| Corporate Officer/Principal | 25 |
| Director/Board Member | 24 |
| Independent Dir/Board Member | 13 |
| Director of Finance/CFO | 10 |
| Undergraduate Degree | 10 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John Smither | 20 |
| James Tyree | 17 |
| Thomas Zindrick | 8 |
| John Thomas | 7 |
| Joseph Cappello | 6 |
| Paul Scigalla | 6 |
| Mary Mirabelli | 6 |
| Sean Ryder | 6 |
| Ralph Smalling | 3 |
| Tony Yu | 3 |
| Qian Zhang | 3 |
| Lourie Zak | 2 |
| Caroline Jewett | 2 |
